Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
CLSA Premium Ltd. ( (HK:6877) ) has provided an announcement.
CLSA Premium Limited announced significant changes in its board of directors, effective April 2025, with the resignation of three directors due to personal and professional reasons. The company expressed gratitude for their contributions and simultaneously appointed new directors, including Mr. Ji Guangfei as the Chairman and CEO, and Ms. Li Jiang as the Deputy Chairman, to lead the company with their extensive experience in corporate management and healthcare.
More about CLSA Premium Ltd.
CLSA Premium Limited is a company incorporated in the Cayman Islands, focusing on corporate management and investment operations across various industries, including medical health, financial investment, and energy. The company is part of a group that includes subsidiaries and is significantly influenced by Beijing Tong Ren Tang (Cayman) Limited, which holds a substantial share in the company.
YTD Price Performance: 245.00%
Average Trading Volume: 4,172,019
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$701.5M
For an in-depth examination of 6877 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue